logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Suven Life Sciences Limited


USPTO Granted Patents = 55

% Expired Patents = 34.5



Forward Citations = 55

Loading Chart...
Loading Chart...

85 inventors (with patents filed for the assignee):

goldMedal Venkateswarlu Jasti (53 out of 59 patents)

silverMedal Ramakrishna Nirogi (37 out of 40 patents)

bronzeMedal Anil Karbhari Shinde (35 out of 37 patents)

4.  Abdul Rasheed Mohammed (19 out of 20 patents)

5.  Pradeep Jayarajan (19 out of 20 patents)

6.  Rama Sastri Kambhampati (16 out of 17 patents)

7.  Gopinadh Bhyrapuneni (12 out of 13 patents)

8.  Venkata Satya Nirogi Ramakrishna (9 out of 10 patents)

9.  Ramasastri Kambhampati (8 out of 9 patents)

10.  Vijay Sidram Benade (7 out of 7 patents)

11.  Ishtiyaque Ahmad (7 out of 12 patents)

12.  Rajesh Kumar Badange (6 out of 6 patents)

13.  Nagaraj Vishwottam Kandikere (6 out of 6 patents)

14.  Venkata Satya Veerabhadra Vadlamudi Rao (6 out of 7 patents)

15.  Ramkumar Subramanian (5 out of 5 patents)


Core Competencies:
5-HT Receptor Antagonists
Muscarinic M1 Modulators
CNS Disorders
Pharmaceutical Compositions
Histamine H3 Ligands
Piperidine Compounds
Tetracyclic Indoles
Acrylamide Compounds
Behavioral Symptoms
Psychological Symptoms

55 patents:

1. 12721846 - Methods for treating behavioral and psychological symptoms in patients with dementia (2026-09-01),
2. 12629365 - Pharmaceutical compositions of 5-HTreceptor antagonist (2026-05-19),
3. 12397003 - Amorphous pharmaceutical compositions of abiraterone acetate (2025-08-26),
4. 12391698 - Substituted piperidines and piperazines and methods for the treatment of CNS disorders (2025-08-19),
5. 12338236 - Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders (2025-06-24),
6. 12285421 - Uses of a 5-HT4 receptor agonist (2025-04-29),
7. 12275746 - Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists (2025-04-14),
8. 12156871 - Substituted azacycles as muscarinic M1 receptor positive allosteric modulators (2024-12-03),
9. 12122779 - Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators (2024-10-22),
10. 11622967 - Method of treatment with histamine-3 receptor inverse agonist (2023-04-11),
11. 11458135 - Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors (2022-10-04),
12. 11278530 - Polycyclic amides as muscarinic M1 receptor positive allosteric modulators (2022-03-22),
13. 11253514 - Triple combination of pure 5-HTreceptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist (2022-02-22),
14. 11234979 - Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators (2022-02-01),
15. 11116764 - Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist (2021-09-14),
Company Overview
Suven Life Sciences Limited, based in Hyderabad, Telangana, specializes in the development and commercialization of innovative pharmaceutical solutions targeting central nervous system (CNS) disorders. The company focuses on advanced therapeutic compounds, including 5-HT receptor antagonists and muscarinic M1 modulators, to address various neurological conditions. With a strong emphasis on research and development, Suven is committed to enhancing treatment options through its expertise in CNS-related pharmaceutical compositions and novel ligand technologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

55 Patents

#3 in Hyderabad Telangana

#34 in India

#12,903 in the World

Hyderabad Telangana, IN
Hyderabad Telangana, India

Suven Life Sciences Limited

Forward Citations = 55

85 inventors:

goldMedal Venkateswarlu Jasti (53 out of 59 patents)

silverMedal Ramakrishna Nirogi (37 out of 40 patents)

bronzeMedal Anil Karbhari Shinde (35 out of 37 patents)

4.  Abdul Rasheed Mohammed (19 out of 20 patents)

5.  Pradeep Jayarajan (19 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Suven Life Sciences Limited. Retrieved from https://idiyas.com/company/suven-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…